Healthcare provider profile · identity verified

Haritha Devi Sirigiri, M.D.

Internal Medicine · AUSTIN, TX · NPI 1881841716

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	332	197
Gabapentin	Gabapentin	219	135
Pantoprazole Sodium	Pantoprazole Sodium	215	130
Furosemide	Furosemide	210	116
Ondansetron Odt	Ondansetron	196	169
Eliquis	Apixaban	188	79
Amlodipine Besylate	Amlodipine Besylate	183	111
Tamsulosin Hcl	Tamsulosin Hcl	156	81
Carvedilol	Carvedilol	128	70
Levothyroxine Sodium	Levothyroxine Sodium	124	78
Metoprolol Tartrate	Metoprolol Tartrate	118	68
Methocarbamol	Methocarbamol	117	75
Trazodone Hcl	Trazodone Hcl	111	69
Losartan Potassium	Losartan Potassium	104	66
Potassium Chloride	Potassium Chloride	100	68
Clopidogrel	Clopidogrel Bisulfate	93	55
Oxycodone Hcl	Oxycodone Hcl	92	59
Albuterol Sulfate Hfa	Albuterol Sulfate	88	65
Metformin Hcl	Metformin Hcl	81	52
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	78	56
Hydralazine Hcl	Hydralazine Hcl	77	49
Insulin Lispro Kwikpen U-100	Insulin Lispro	77	58
Sertraline Hcl	Sertraline Hcl	75	42
Lisinopril	Lisinopril	69	40
Metoprolol Succinate	Metoprolol Succinate	68	49
Duloxetine Hcl	Duloxetine Hcl	67	39
Enoxaparin Sodium	Enoxaparin Sodium	64	39
Levetiracetam	Levetiracetam	64	28
Fluticasone Propionate	Fluticasone Propionate	63	47
Pravastatin Sodium	Pravastatin Sodium	61	32
Rosuvastatin Calcium	Rosuvastatin Calcium	60	42
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	55	37
Torsemide	Torsemide	53	36
Montelukast Sodium	Montelukast Sodium	52	38
Prednisone	Prednisone	49	29
Spironolactone	Spironolactone	48	30
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	34
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	45	32
Ondansetron Hcl	Ondansetron Hcl	45	35
Tramadol Hcl	Tramadol Hcl	45	35
Baclofen	Baclofen	42	30
Sure Comfort Pen Needle	Pen Needle, Diabetic	40	40
Allopurinol	Allopurinol	39	23
Cephalexin	Cephalexin	39	24
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	29
Clonidine Hcl	Clonidine Hcl	38	27
Hydroxyzine Hcl	Hydroxyzine Hcl	38	22
Jardiance	Empagliflozin	37	21
Mirtazapine	Mirtazapine	36	25
Escitalopram Oxalate	Escitalopram Oxalate	35	21
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	34	18
Albuterol Sulfate	Albuterol Sulfate	33	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	18
Omeprazole	Omeprazole	33	26
Pregabalin	Pregabalin	33	17
Lactulose	Lactulose	32	27
Latanoprost	Latanoprost	32	17
Midodrine Hcl	Midodrine Hcl	31	21
Tizanidine Hcl	Tizanidine Hcl	31	18
Xarelto	Rivaroxaban	30	15
Celecoxib	Celecoxib	29	21
Ezetimibe	Ezetimibe	29	21
Sevelamer Carbonate	Sevelamer Carbonate	29	20
Famotidine	Famotidine	28	25
Quetiapine Fumarate	Quetiapine Fumarate	28	17
Doxycycline Hyclate	Doxycycline Hyclate	27	18
Bupropion Xl	Bupropion Hcl	25	12
Oxybutynin Chloride	Oxybutynin Chloride	25	14
Alendronate Sodium	Alendronate Sodium	24	12
Amiodarone Hcl	Amiodarone Hcl	24	15
Sodium Chloride	0.9 % Sodium Chloride	24	23
Calcium Acetate	Calcium Acetate	23	14
Citalopram Hbr	Citalopram Hydrobromide	23	13
Januvia	Sitagliptin Phosphate	23	11
Donepezil Hcl	Donepezil Hcl	22	17
Glipizide	Glipizide	22	15
Nifedipine Er	Nifedipine	22	15
Alprazolam	Alprazolam	20	14
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Humalog Kwikpen U-100	Insulin Lispro	20	18
Metolazone	Metolazone	20	14
Buspirone Hcl	Buspirone Hcl	19	13
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Levemir Flexpen	Insulin Detemir	18	14
Meclizine Hcl	Meclizine Hcl	18	13
Nystatin	Nystatin	18	15
Olanzapine	Olanzapine	18	15
Ciprofloxacin Hcl	Ciprofloxacin Hcl	17	15
Hydrochlorothiazide	Hydrochlorothiazide	17	14
Levofloxacin	Levofloxacin	17	11
Nitroglycerin	Nitroglycerin	17	11
Ropinirole Hcl	Ropinirole Hcl	17	suppressed
Warfarin Sodium	Warfarin Sodium	17	suppressed
Finasteride	Finasteride	16	11
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	13
Budesonide	Budesonide	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	15	11
Folic Acid	Folic Acid	15	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Simvastatin	Simvastatin	15	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	15	suppressed
Xifaxan	Rifaximin	15	suppressed
Entresto	Sacubitril/Valsartan	14	11
Fentanyl	Fentanyl	14	suppressed
Insulin Lispro	Insulin Lispro	14	14
Lidocaine	Lidocaine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	11
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Gemtesa	Vibegron	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	13	12
Lamotrigine	Lamotrigine	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Nystop	Nystatin	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	11
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Estradiol	Estradiol	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Memantine Hcl Er	Memantine Hcl	11	suppressed
Metformin Hcl Er	Metformin Hcl	11	suppressed
Sevelamer Hcl	Sevelamer Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error